The effects of hyperbaric oxygen therapy on neuroprotection and recovery after brain resuscitation.

OBJECTIVE

Analyze the impact of hyperbaric oxygen therapy on neuroprotection and recovery post severe traumatic brain injury (sTBI) resuscitation.

METHODS

Retrospective analysis of clinical data from 83 sTBI patients admitted between January 2022 to January 2024. Patients were divided into control ( = 41) and observation ( = 42) groups based on treatment received. Control received standard therapy, while the observation group received hyperbaric oxygen therapy. Effects on clinical outcomes, neuroinjury markers (S100β, GFAP, UCH-L1, NSE), neurotrophic factors (NGF, BDNF), neurological function indicators (NIHSS, CSS), and adverse reactions were compared.

RESULTS

The observation group showed a higher total effective rate (80.95%) compared to control (60.98%) ( < 0.05). Neuroinjury markers decreased post-treatment in both groups, with the observation group lower ( < 0.05). NGF and BDNF levels increased post-treatment in both groups, with the observation group higher ( < 0.05). NIHSS and CSS scores decreased post-treatment in both groups, with the observation group lower ( < 0.05). No significant difference in adverse reactions between groups ( > 0.05).

CONCLUSION

Hyperbaric oxygen therapy effectively treats sTBI by improving brain resuscitation success, reducing neuroinjury factors, enhancing neurotrophic factors, and promoting neurological function recovery, without increasing adverse reaction risk.